Results 111 to 120 of about 60,842 (297)
ABSTRACT The case discussed involves a 41‐year‐old Italian man who was a candidate for chimeric antigen receptor T‐cell therapy (CAR‐T) for mediastinal diffuse large B‐cell lymphoma. His CAR‐T treatment was postponed several times due to prolonged relapsing COVID‐19 and new onset of pulmonary Mycobacterium tuberculosis diseases.
Monica Melchio +10 more
wiley +1 more source
Necrotizing osteomyelitis in a man with disseminated Mycobacterium chelonae infection
Cases of disseminated nontuberculous mycobacterial (NTM) infection are difficult to treat. We encountered an elderly man with disseminated Mycobacterium chelonae infection.
Garrett M. Harp +2 more
doaj +1 more source
Laboratory Diagnosis of Mycobacterial Infections: New Tools and Lessons Learned [PDF]
Even in the 21st century, tuberculosis continues to be a problem. Although the number of cases continues gradually to decrease in the United States, cases get more difficult to treat, specifically those that are multiple-drug resistant.
Hale, Yvonne M. +4 more
core
Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections.
The incidence and prevalence of nontuberculous mycobacterial lung disease (NTM-LD) is rising worldwide and accounts for most clinical cases of NTM. NTM infections occur in both immunocompetent and immunocompromised hosts. Macrophages are the primary host
Zohra Prasla, R. Sutliff, R. Sadikot
semanticscholar +1 more source
Granulysin Antimicrobial Activity Promotes Dormancy in Mycobacterium tuberculosis
Exploiting a high‐dimensional mass cytometry approach, we demonstrate that CD56+ lymphocytes promote Mycobacterium tuberculosis dormancy by delivering granulysin, a cytotoxic effector molecule with known antimicrobial activity. ABSTRACT Human tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) remains a global public health threat.
Sarah Schmidiger +17 more
wiley +1 more source
Pulmonary Infection and Colonization with Nontuberculous Mycobacteria, Taiwan, 2000–2012
We analyzed samples from 13,652 patients who had respiratory cultures positive for mycobacteria in Taiwan during 2000–2012 and found that 56.9% were positive for nontuberculous mycobacteria (NTM).
Jung-Yien Chien +4 more
doaj +1 more source
Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review.
V. N. Dahl +7 more
semanticscholar +1 more source
Patients with autoantibodies to IFN-γ may develop severe nontuberculous mycobacterial infections. We describe the novel use of daratumumab in a patient with autoantibodies to IFN-γ who had progressive infection, resulting in clinical and radiographic ...
S. Ochoa +5 more
semanticscholar +1 more source
Lenvatinib‐Associated Non‐Tuberculous Mycobacterial Pulmonary Disease: A Case Report
This article presents a case of a hepatocellular carcinoma patient who developed pulmonary NTM infection after long‐term lenvatinib therapy, as detected by next‐generation sequencing (NGS). Symptoms improved and follow‐up CT showed resolution after discontinuation of lenvatinib for 2 months.
Qian Wang +3 more
wiley +1 more source
The identification of Mycobacteria in the species level has great medical importance. Biochemical tests are laborious and time-consuming, so new techniques could be used to identify the species.
Shafipour1, M. +4 more
doaj

